Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27761219 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL27728903 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL5708956 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL27521301 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL5182538 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL21681230 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL3165864 | 1.00 | NAAA (0.55) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL2138746 | 0.98 | NAAA (0.53) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL447114 | 0.98 | NAAA (0.53) | NAAAEPHX1TSHRDGKAHTR2C | |
| SCHEMBL10867096 | 0.98 | NAAA (0.53) | NAAAEPHX1TSHRDGKAHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020023752-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-01-30 | — | — | WO | claimed |
| JP-4198107-A | — | — | None | — | — | JP | disclosed |
| US-20200030716-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2020-01-30 | — | — | US | disclosed |
| WO-2020023752-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-01-30 | — | — | WO | disclosed |
| US-9302274-B2 | Collector compositions and methods of using the same | CYTEC TECHNOLOGY CORP. (US) | 2016-04-05 | — | — | US | disclosed |
| EP-2768616-A2 | COLLECTOR COMPOSITIONS AND METHODS OF USING THE SAME | Cytec Technology Corp. (US) | 2014-08-27 | — | — | EP | disclosed |
| EP-1840399-B1 | COLLAPSIBLE COLUMN | NSK LTD (JP) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013059258-A2 | COLLECTOR COMPOSITIONS AND METHODS OF USING THE SAME | CYTEC TECHNOLOGY CORP. (US) | 2013-04-25 | — | — | WO | disclosed |
| US-20130092603-A1 | Collector Compositions and Methods of Using the Same | CYTEC TECHNOLOGY CORP. (US) | 2013-04-18 | — | — | US | disclosed |
| EP-1840399-A1 | COLLAPSIBLE COLUMN | NSK Ltd., (JP) | 2007-10-03 | — | — | EP | disclosed |
| EP-1136545-A2 | Lubricating grease composition and rolling apparatus comprising same | NSK LTD (JP) | 2001-09-26 | — | — | EP | disclosed |
| JP-H04198107-A | UNDERWATER ANITIFOULING AGENT COMPOSITION | TOKYO ORGAN CHEM IND LTD | 1992-07-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200030716-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | SOD1, SOD3, SLC39A11 | NAAA 903/4885EPHX1 2776/4885TSHR 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.